Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Cell Cycle Control System01:28

The Cell Cycle Control System

5.3K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The WYZ-1 mouse glioblastoma stem cell model: A novel preclinical tool for tumor and therapy studies.

Cancer letters·2026
Same author

Acid Ceramidase Inhibition Disrupts Ceramide Homeostasis and Induces Mitochondrial Apoptosis in IDH1-Mutant Oligodendroglioma.

Research square·2026
Same author

Cancer Metabolism Meets DNA Repair: The Hidden Link to Therapy Resistance.

BioEssays : news and reviews in molecular, cellular and developmental biology·2025
Same author

Molecular Dynamics Simulation on Orientation-Dependent Mechanical Behaviors of ZnO Single Crystals Under Nanoindentation.

Materials (Basel, Switzerland)·2025
Same author

Development of succinate dehydrogenase subunit B-deficient tumor models for preclinical immunotherapy testing.

Cancer letters·2025
Same author

mtKO: A dedicated guide RNA library for mitochondria research.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Jan 16, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.2K

Targeting cell cycle checkpoints for glioma therapy.

Fengchao Lang1, Chunzhang Yang1

  • 1Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, MD 20892, USA.

Pharmacology & Therapeutics
|October 3, 2025
PubMed
Summary

Glioma treatment is limited, but targeting the cell cycle offers promise. This review details glioma cell cycle patterns and emerging therapies for this devastating brain tumor.

Keywords:
Cell cycleCheckpointCyclin dependent kinaseGliomaMyt1 kinase

More Related Videos

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.7K
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

10.7K

Related Experiment Videos

Last Updated: Jan 16, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.2K
Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.7K
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

10.7K

Area of Science:

  • Neuro-oncology
  • Cancer biology
  • Molecular medicine

Background:

  • Glioma is an aggressive brain tumor with poor prognosis.
  • Current treatments like surgery, radiation, and chemotherapy provide limited survival benefits.
  • Glioma's rapid proliferation is driven by dysregulated cell cycle mechanisms.

Purpose of the Study:

  • To review the unique cell cycle molecular patterns in glioma.
  • To discuss novel targeted therapies focused on glioma cell cycle regulators.

Main Methods:

  • Literature review of glioma cell cycle mechanisms.
  • Analysis of emerging targeted therapeutic strategies.

Main Results:

  • Distinct molecular alterations in the cell cycle are characteristic of glioma.
  • Targeting cell cycle checkpoints presents a promising therapeutic avenue.

Conclusions:

  • Understanding glioma cell cycle dysregulation is crucial for developing effective treatments.
  • Targeted therapies offer potential for improved clinical outcomes in glioma patients.